HCPCS Level IIdrugActive
J0257
Glassia injection
BETOS: O1E
Effective: 2012-01-01
Referenced in 2 policies
Description
Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Glassia
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
10 MG
Billing Units
0.1000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.